Intel Acquires Docea Power

Graftys: broadening indication to bone marrow lesions (BML)
14 September 2015
Initiative Octalfa at the BIO 2015
1 June 2015

Intel Acquires Docea Power

The acquisition of the Grenoble-based company by INTEL was closed July 31st 2015.